RNA, U6atac small nuclear 4, pseudogene (RNU6ATAC4P)

RNA, U6atac small nuclear 4, pseudogene (RNU6ATAC4P) is classified as a pseudogene of the U6atac small nuclear RNA (snRNA) gene family. U6atac snRNA is a critical component of the "minor" spliceosome, a cellular complex involved in the splicing of a specific subset of introns called U12-type introns in pre-messenger RNA, thereby regulating gene expression post-transcriptionally[1]. The actual U6atac snRNA has important biological and disease relevance, modulating expression of numerous genes involved in cell signaling, stress response, and minor intron splicing[1]. However, RNU6ATAC4P is a pseudogene, meaning it is a non-functional genomic sequence related to a functional gene but does not encode a functional product—in this case, it does not produce a functional U6atac snRNA and lacks characterized biological function or relevance as a therapeutic target. Pseudogenes such as RNU6ATAC4P do not produce active molecules, do not participate directly in recognized cellular or disease processes, and are not targets of any drugs or therapeutics, nor used as biomarkers. The entry is likely incorrect as a therapeutic target because pseudogenes are not considered actionable molecular targets in drug discovery or clinical settings. Summary: RNU6ATAC4P (RNA, U6atac small nuclear 4, pseudogene) is a non-coding RNA pseudogene, not an active molecule or therapeutic target. It has no known biological, disease, or therapeutic relevance, and listing it as a target is incorrect. The active analog is the U6atac small nuclear RNA, which is a functional component of the minor spliceosome[1].

Other names

RNU6ATAC4P